A Small Molecule That In Vitro Neutralizes Infection of SARS-CoV-2 and Its Most Infectious Variants, Delta, and Omicron

The COVID-19 pandemic has underscored the urgent need to develop highly potent and safe medications that are complementary to the role of vaccines. Specifically, it has exhibited the need for orally bioavailable broad-spectrum antivirals that are able to be quickly deployed against newly emerging vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes-Alcaraz, Arfaxad, Qasim, Hanan, Merlinsky, Elizabeth, Fox, Glenn, Islam, Tasneem, Medina, Bryan, Schwartz, Robert J., Craft, John W., McConnell, Bradley K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046252/
https://www.ncbi.nlm.nih.gov/pubmed/36979895
http://dx.doi.org/10.3390/biomedicines11030916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046252/
https://www.ncbi.nlm.nih.gov/pubmed/36979895
http://dx.doi.org/10.3390/biomedicines11030916

Ejemplares similares